A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 365 participants.

Also called NCT02345057

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 365 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02345057
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02345057. Randomized; quadruple masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2016-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria
Condition
Diabetic Nephropathy
Intervention (Drug)
CS-3150
Intervention (Drug)
placebo
Lead sponsor
Daiichi Sankyo (class: industry)

Record details

Record id
cardio:ct-nct02345057
Content hash
52ea4c0f740ec10593f5827ac1b8375f7111e721fde4c5b3ff4ae5939800105f